Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Preventing death and limiting handicap from ischaemic stroke are major goals that can be achieved only if the pathophysiology of infarct expansion is properly understood. Primate studies showed that following occlusion of the middle cerebral artery (MCA)––the most frequent and prototypical stroke, local tissue fate depends on the severity of hypoperfusion and duration of occlusion, with a fraction of the MCA territory being initially in a ‘penumbral’ state. Physiological quantitative PET imaging has translated this knowledge in man and revealed the presence of considerable pathophysiological heterogeneity from patient to patient, largely unpredictable from elapsed time since onset or clinical deficit. While these observations underpinned key trials of thrombolysis, they also indicate that only patients who are likely to benefit should be exposed to its risks. Accordingly, imaging‐based diagnosis is rapidly becoming an essential component of stroke assessment, replacing the clock by individually customized management. Diffusion‐ and perfusion‐weighted MR (DWI‐PWI) and CT‐based perfusion imaging are increasingly being used to implement this, and are undergoing formal validation against PET. Beyond thrombolysis per se, knowledge of the individual pathophysiology also guides management of variables like blood pressure, blood glucose and oxygen saturation, which can otherwise precipitate the penumbra into the core, and the oligaemic tissue into the penumbra. We propose that future therapeutic trials use physiological imaging to select the patient category that best matches the drug's presumed mode of action, rather than lumping together patients with entirely different pathophysiological patterns in so‐called ‘large trials’, which have all failed so far. British Journal of Pharmacology (2008) 153, S44–S54; doi:10.1038/sj.bjp.0707530; published online 26 November 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662 · cited 1×
“This manifests as massive efflux of Kþ and reciprocal influx of Naþ , water and Caþ þ with consequent anoxic depolarization (Branston et al., 1977; Harris et al., 1981) and eventually cell death.”
Thresholds in cerebral ischemia - the ischemic penumbra.
Astrup, J., Siesjö, B. K., & Symon, L. (1981) · Stroke · doi:10.1161/01.str.12.6.723 · Cited by 2,820 · cited 3×
“Interruption of blood flow to the supplied basal ganglia, white matter and cortex causes a gradient of hypoperfusion to emerge (Figure 1), rather than complete and homogeneous ischaemia of the entire MCA territory (Astrup et al., 1981).”
BackgroundInfluentialFeigin, V. L., Lawes, C. M., Bennett, D. A., & Anderson, C. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00266-7 · Cited by 1,932
Selective Ablation of Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain
Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., & Kriz, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5360-06.2007 · Cited by 874
Schilling, M., Besselmann, M., Leonhard, C., Mueller, M., Ringelstein, E. B., & Kiefer, R. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00082-7 · Cited by 375
Perfusion Thresholds in Human Cerebral Ischemia: Historical Perspective and Therapeutic Implications
Baron, J.-C. (2001) · Cerebrovascular Diseases · doi:10.1159/000049119 · Cited by 352
Self-citationMabuchi, T., Kitagawa, K., Ohtsuki, T., Kuwabara, K., Yagita, Y., Yanagihara, T., Hori, M., & Matsumoto, M. (2000) · Stroke · doi:10.1161/01.str.31.7.1735 · Cited by 280 · cited 2×
“Animal studies suggest that microglial activation also extends beyond the core and could contribute to peri-infarct neuronal death (Mabuchi et al., 2000).”
BackgroundFuture of neuroprotection for acute stroke: In the aftermath of the SAINT trials
Savitz, S. I., & Fisher, M. (2007) · Annals of Neurology · doi:10.1002/ana.21127 · Cited by 267
Cited by
Mitochondria in neuroplasticity and neurological disorders
Mattson, M. P., Gleichmann, M., & Cheng, A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.010 · Cited by 1,081
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
“For this reason, TSPO imaging has become a valuable tool for assessing brain lesions with considerable pathophysiological heterogeneity, such as those observed in stroke patient”
MethodWadas, T. J., Wong, E. H., Weisman, G. R., & Anderson, C. J. (2010) · Chemical Reviews · doi:10.1021/cr900325h · Cited by 924
Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
Rodrigo, R., Fernandez-Gajardo, R., Gutierrez, R., Matamala, J., Carrasco, R., Miranda-Merchak, A., & Feuerhake, W. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050015 · Cited by 640
A new penumbra: transitioning from injury into repair after stroke
Lo, E. H. (2008) · Nature Medicine · doi:10.1038/nm1735 · Cited by 611
Metadata
- Authors
- Moustafa, R. R., & Baron, J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 153
- Issue
- S1
- Pages
- S44-54
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2117292779
- Cited by
- 124
- References
- 8
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. https://app.cochat.ai/papers/10.1038/sj.bjp.0707530
- The paper
- Moustafa, R. R., & Baron, J. (2008). Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0707530
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.